This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Massimo Tommasino: Innovator in Immunogenic Polypeptides
Introduction
Massimo Tommasino is a notable inventor based in Charly-Lyon, Italy. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing immunogenic polypeptides that have the potential to advance vaccine technology.
Latest Patents
Massimo Tommasino holds a patent for "Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or a fragment thereof." This invention relates to an immunogenic polypeptide that includes a scaffold polypeptide and a L2 polypeptide or a fragment thereof. The scaffold polypeptide is designed to constrain the structure of the L2 polypeptide, enhancing its immunogenic properties. Additionally, the invention encompasses a vaccine that includes this immunogenic polypeptide and a method for producing an antibody against human papillomavirus.
Career Highlights
Massimo Tommasino is affiliated with the Deutsches Krebsforschungszentrum, where he continues to contribute to cancer research and immunology. His work has been instrumental in advancing the understanding of immunogenic responses and developing new therapeutic strategies.
Collaborations
Some of his notable coworkers include Simone Ottonello and Martin Mueller, who collaborate with him on various research projects aimed at improving vaccine efficacy and understanding immune responses.
Conclusion
Massimo Tommasino's innovative work in immunogenic polypeptides highlights his commitment to advancing medical science and improving public health through effective vaccines. His contributions are paving the way for future developments in immunology and vaccine research.